Nitric BioTherapeutics, Inc. — Form D
Nitric BioTherapeutics, Inc. of BRISTOL, PA, a company, filed a Form D exempt-offering notice with the SEC on 2010-07-12. The offering totals $6.0M, of which $1.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-07-12
- Form: D
- Accession: 0001460586-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $1.8M
- Remaining: $4.3M
- Investors: 6
- Date of first sale: 2010-06-29
- Security types: equity, debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-144732
Issuer
- Name: Nitric BioTherapeutics, Inc.
- CIK: 0001460586
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: 2 CANAL'S END ROAD, BRISTOL, PA, 19007
- Phone: 215-788-6200
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Matthew M Rieke | Director | Bristol, PA |
| Marcus J Schabacker | Director | Bristol, PA |
| Zev Scherl | Director | Long Beach, CA |
| Brian M Gallagher | Director | Cambridge, MA |
| Matthew Rieke | Director | Philadelphia, PA |
| Frank J McCaney | Director | Bristol, PA |
| Frank J McCaney | Executive Officer | Bristol, PA |
| Al M Altomari | Director | Bristol, PA |
| Adele M Oliva | Director | Bristol, PA |
| Jeffrey M O'Donnell | Director | Bristol, PA |
| Zev M Scherl | Director | Bristol, PA |
| James J Ratigan | Executive Officer | Bristol, PA |
| Richard Caruso | Director | Villanova, PA |
| Harold Chefitz | Director | Bristol, PA |
| Hugh MacNaught | Director | Bristol, PA |
Other filings by this issuer (3)
More